Amneal Pharmaceuticals Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Amneal Pharmaceuticals Inc 's ROA in the second quarter of 2026?
Amneal Pharmaceuticals Inc achieved a return on average assets (ROA) of 5.89 % in its second quarter of 2026, this is above AMRX's average return on assets of -2.44%.
Amneal Pharmaceuticals Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $3 billion

Despite the company's net income deteriorating, Amneal Pharmaceuticals Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 143 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1161, from total ROA ranking in the first quarter of 2026 at 1711.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	10.24 %	5.2 %	5.61 %	4.02 %	-24.39 %
Y / Y Net Income Change	95.49 %	216.84 %	-	54.22 %	112.13 %
Net Income (TTM) in million	215	181	128	58	51
Return On Assets (TTM)	5.89 %	5.08 %	3.63 %	1.66 %	1.49 %
AMRX's Total Ranking	# 1161	# 1711	# 1935	# 1978	# 2206
Total Assets (TTM) in million	3,773	3,540	3,702	3,600	3,423
Seq. Total Assets Change	6.59 %	-4.38 %	2.85 %	5.17 %	1.71 %
Seq. Net Income Change	-10.75 %	57.34 %	173.4 %	-49.08 %	44.65 %

AMRX's 5 Years Annual ROA >> Back to AMRX Management Effectiveness >> Compare AMRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 55
Sector	# 144
Overall	# 1040

Return On Assets Statistics
High	Average	Low
5.9 %	-2.44 %	-13.15 %
(Jun 30 2026)		(Dec 31 2019)

Financial Statements
Amneal Pharmaceuticals Inc 's Assets	$ 3,773 million	AMRX's Balance sheet
Amneal Pharmaceuticals Inc 's Income	$ 70 million	Quarterly AMRX's Income Statement
AMRX's Income by Division		See AMRX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	5.05 %	0.83 %	-8.6 %	-3.56 %	-16.17 %
Total Assets in million	3,678	3,501	3,473	3,799	3,940
Y / Y Net Income Change	-	-	-	-	-70.59 %
Net Income in million	128	-74	-49	-255	20
Annual Return On Assets	3.48 %	-2.11 %	-1.4 %	-6.71 %	0.51 %

AMRX's 5 Years Annual ROA >> Back to AMRX Management Effectiveness >> Compare AMRX ROA to its Competitors

Comment on AMRX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 3.48 % compared to prior year, due to annual net income growth of % to $127.93 million, while value of Amneal Pharmaceuticals Inc 's overall assets grew just by 5.05 % to $3,678.28 million, compared to $3,678.28 a year before.

More Return On Assets Ratios
AMRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AMRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AMRX's Competitors
Subscribers only: Roa for Amneal Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for AMRX's Customers

You may also want to know
AMRX's Roi	AMRX's Inventory Turnover Ratio	AMRX's Growth Rates	AMRX's Dividend Comparisons
	AMRX's Profitability Ratios	AMRX's Asset Turnover Ratio	AMRX's Dividend Growth
AMRX's Roe	AMRX's Valuation Ratios	AMRX's Financial Strength Ratios	AMRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %
Msa Safety Inc	12.23 %
Strata Critical Medical Inc	12.18 %
Insulet Corporation	12.13 %
Lantheus Holdings Inc	11.89 %
Ligand Pharmaceuticals Incorporated	11.68 %
Theravance Biopharma inc	11.68 %
Carlisle Companies Incorporated	11.62 %
Encompass Health Corporation	11.60 %

Date modified: 2026-09-08T16:31:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.